Case 29-2005: A 68-year-old man with periorbital swelling, rash, and weakness

New England Journal of Medicine

Volumn 353, Issue 12, 2005, Pages 1275-1284

  Polisson, Richard P ^a,b   Crocker, Jonathan T ^a,b   Mueller, Peter R ^a,b   Harris, Nancy Lee ^a,b   Duncan, Lyn M ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; ISONIAZID; METHYLPREDNISOLONE; OMEPRAZOLE;

AGED; ARTICLE; BIOPSY; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GASTROINTESTINAL ENDOSCOPY; GLAUCOMA; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; MALE; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PRIORITY JOURNAL; RASH; B CELL LYMPHOMA; BLOOD ANALYSIS; CLINICAL OBSERVATION; CLINICAL STUDY; DERMATOMYOSITIS; DIAGNOSIS; ECHOGRAPHY; EDEMA; EYE DISEASE; HISTIOCYTIC LYMPHOMA; PATHOLOGY; RADIOGRAPHY; SKELETAL MUSCLE; SKIN; SPLEEN; SPLEEN TUMOR;

AGED; BLOOD CHEMICAL ANALYSIS; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; EDEMA; EXANTHEMA; EYE DISEASES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MALE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; SKIN; SPLEEN; SPLENIC NEOPLASMS;

EID: 25144454517     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc059025     Document Type: Article

References (30)

1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23.
2. Physician's desk reference. 58th ed. Montvale, N.J.: Thomson PDR, 2004.
3. Odeh M, Lurie M, Oliven A. Cutaneous leucocytoclastic vasculitis associated with omeprazole. Postgrad Med J 2002;78:114-5.
4. Zuckner J. Drug-induced myopathies. Semin Arthritis Rheum 1990;19:259-68.
5. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7, 403-7.
6. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-86.
7. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.
8. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-13.
9. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989;111:143-57.
10. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980;59:239-48.
11. Ringel RA, Brick JE, Brick JF, Gutmann L, Riggs JE. Muscle involvement in the scleroderma syndromes. Arch Intern Med 1990;150:2550-2.
12. Tymms KE, Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 1985;12:1140-8.
13. Park JH, Olsen NJ, King L Jr, et al. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis Rheum 1995;38:68-77.
14. Reimers CD, Finkenstaedt M. Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 1997;9:475-85.
15. Barnes BE, Mawr B. Dermatomyositis and malignancy: a review of the literature. Ann Intern Med 1976;84:68-76.
16. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992;326:363-7.
17. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study. Ann Intern Med 2001;134:1087-95.
18. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100.
19. Lucey BC, Boland GW, Maher MM, Hahn PF, Gervais DA, Mueller PR. Percutaneous nonvascular splenic intervention: a 10-year review. AJR Am J Roentgenol 2002;179:1591-6.
20. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909-18.
21. Arber DA, Rappaport H, Weiss LM. Non-Hodgkin's lymphoproliferative disorders involving the spleen. Mod Pathol 1997;10:18-32.
22. Kraemer BB, Osborne BM, Butler JJ. Primary splenic presentation of malignant lymphoma and related disorders: a study of 49 cases. Cancer 1984;54:1606-19.
23. Mollejo M, Algara P, Mateo MS, et al. Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol 2003;27:895-902.
24. Spier CM, Kjeldsberg CR, Eyre HJ, Behm FG. Malignant lymphoma with primary presentation in the spleen: a study of 20 patients. Arch Pathol Lab Med 1985;109:1076-80.
25. Falk S, Stutte HJ. Primary malignant lymphomas of the spleen: a morphologic and immunohistochemical analysis of 17 cases. Cancer 1990;66:2612-9.
26. Harris NL, Aisenberg AC, Meyer JE, Ellman L, Elman A. Diffuse large cell (histiocytic) lymphoma of the spleen: clinical and pathologic characteristics of ten cases. Cancer 1984;54:2460-7.
27. Meyer JE, Harris NL, Elman A, Stomper PC. Large-cell lymphoma of the spleen: CT appearance. Radiology 1983;148:199-201.
28. Lindfors KK, Meyer JE, Palmer EL III, Harris NL. Scintigraphic findings in large-cell lymphoma of the spleen: concise communication. J Nucl Med 1984;25:969-71.
29. Case Records of the Massachusetts General Hospital (Case 48-1976). N Engl J Med 1976;295:1242-8.
30. Case Records of the Massachusetts General Hospital (Case 15-1982). N Engl J Med 1982;306:918-25.